218 related articles for article (PubMed ID: 31830799)
1. HIV-1 Integrase Diversity and Resistance-Associated Mutations and Polymorphisms Among Integrase Strand Transfer Inhibitor-Naive HIV-1 Patients from Cameroon.
Mikasi SG; Gichana JO; Van der Walt C; Brado D; Obasa AE; Njenda D; Messembe M; Lyonga E; Assoumou O; Cloete R; Ikomey GM; Jacobs GB
AIDS Res Hum Retroviruses; 2020 May; 36(5):450-455. PubMed ID: 31830799
[TBL] [Abstract][Full Text] [Related]
2. Interaction analysis of statistically enriched mutations identified in Cameroon recombinant subtype CRF02_AG that can influence the development of Dolutegravir drug resistance mutations.
Mikasi SG; Isaacs D; Chitongo R; Ikomey GM; Jacobs GB; Cloete R
BMC Infect Dis; 2021 Apr; 21(1):379. PubMed ID: 33892628
[TBL] [Abstract][Full Text] [Related]
3. Variability in HIV-1 Integrase Gene and 3'-Polypurine Tract Sequences in Cameroon Clinical Isolates, and Implications for Integrase Inhibitors Efficacy.
Acharya A; Tagny CT; Mbanya D; Fonsah JY; Nchindap E; Kenmogne L; Jihyun M; Njamnshi AK; Kanmogne GD
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32106437
[No Abstract] [Full Text] [Related]
4. Short Communication: HIV-1 Drug Resistance Mutation Analyses of Cameroon-Derived Integrase Sequences.
Mikasi SG; Isaacs D; Ikomey GM; Shimba H; Cloete R; Jacobs GB
AIDS Res Hum Retroviruses; 2021 Jan; 37(1):54-56. PubMed ID: 32640829
[TBL] [Abstract][Full Text] [Related]
5. Resistance-Associated Mutations and Polymorphisms among Integrase Inhibitor-Naïve HIV-1 Patients in Kuwait.
Chehadeh W; Albaksami O; John SE; Al-Nakib W
Intervirology; 2017; 60(4):131-137. PubMed ID: 29212076
[TBL] [Abstract][Full Text] [Related]
6. Baseline integrase drug resistance mutations and conserved regions across HIV-1 clades in Cameroon: implications for transition to dolutegravir in resource-limited settings.
Semengue ENJ; Armenia D; Inzaule S; Santoro MM; Dambaya B; Takou D; Teto G; Nka AD; Yagai B; Fabeni L; Chenwi C; Angong Beloumou G; Djupsa Ndjeyep SC; Colizzi V; Perno CF; Ceccherini-Silberstein F; Fokam J
J Antimicrob Chemother; 2021 Apr; 76(5):1277-1285. PubMed ID: 33501504
[TBL] [Abstract][Full Text] [Related]
7. Absence of Integrase Strand Transfer Inhibitor Associated Resistance in Antiretroviral Therapy Naïve and Experienced Individuals from Western India.
Karade S; Sen S; Sashindran VK
AIDS Res Hum Retroviruses; 2019 Jun; 35(6):567-571. PubMed ID: 30793915
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of integrase strand transfer inhibitor resistance mutations in antiretroviral-naive HIV-1-infected individuals in Cameroon.
Wenk BM; Mbunkah HA; Nsanwe NN; Mbu ET; Besong LM; Sama BA; Orock E; Leemann C; Metzner KJ
J Antimicrob Chemother; 2021 Jan; 76(1):124-129. PubMed ID: 32954411
[TBL] [Abstract][Full Text] [Related]
9. Circulating HIV-1 Integrase Genotypes in Tanzania: Implication on the Introduction of Integrase Inhibitors-Based Antiretroviral Therapy Regimen.
Masoud S; Kamori D; Barabona G; Mahiti M; Sunguya B; Lyamuya E; Ueno T
AIDS Res Hum Retroviruses; 2020 Jun; 36(6):539-543. PubMed ID: 32126792
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 Genetic Diversity and Natural Polymorphisms of the Integrase Gene in Integrase Inhibitor-Naive Patients in Harare, Zimbabwe.
Madyadi A; Dhoro M; Shamu T; Washaya T; Kouamou V; Chimukangara B; Katzenstein D; Manasa J
AIDS Res Hum Retroviruses; 2021 Dec; 37(12):954-961. PubMed ID: 34714124
[TBL] [Abstract][Full Text] [Related]
11. Natural polymorphism S119R of HIV-1 integrase enhances primary INSTI resistance.
Hachiya A; Ode H; Matsuda M; Kito Y; Shigemi U; Matsuoka K; Imamura J; Yokomaku Y; Iwatani Y; Sugiura W
Antiviral Res; 2015 Jul; 119():84-8. PubMed ID: 25956162
[TBL] [Abstract][Full Text] [Related]
12. Analyses of HIV-1 integrase sequences prior to South African national HIV-treatment program and available of integrase inhibitors in Cape Town, South Africa.
Brado D; Obasa AE; Ikomey GM; Cloete R; Singh K; Engelbrecht S; Neogi U; Jacobs GB
Sci Rep; 2018 Mar; 8(1):4709. PubMed ID: 29549274
[TBL] [Abstract][Full Text] [Related]
13. Primary resistance to integrase strand transfer inhibitors in patients infected with diverse HIV-1 subtypes in sub-Saharan Africa.
Inzaule SC; Hamers RL; Noguera-Julian M; Casadellà M; Parera M; Rinke de Wit TF; Paredes R
J Antimicrob Chemother; 2018 May; 73(5):1167-1172. PubMed ID: 29462322
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Integrase Strand Transfer Inhibitors Resistance Mutations in Integrase Strand Transfer Inhibitors-Naive and -Experienced HIV-1 Infected Patients: A Single Center Experience.
De Francesco MA; Izzo I; Properzi M; Gargiulo F; Caccuri F; Quiros-Roldan E; Castelli F; Caruso A; Focà E
AIDS Res Hum Retroviruses; 2018 Jul; 34(7):570-574. PubMed ID: 29631420
[TBL] [Abstract][Full Text] [Related]
15. Molecular dynamic simulations to investigate the structural impact of known drug resistance mutations on HIV-1C Integrase-Dolutegravir binding.
Chitongo R; Obasa AE; Mikasi SG; Jacobs GB; Cloete R
PLoS One; 2020; 15(5):e0223464. PubMed ID: 32379830
[TBL] [Abstract][Full Text] [Related]
16. Genetic barriers for integrase inhibitor drug resistance in HIV type-1 B and CRF02_AG subtypes.
Maïga AI; Malet I; Soulie C; Derache A; Koita V; Amellal B; Tchertanov L; Delelis O; Morand-Joubert L; Mouscadet JF; Murphy R; Cissé M; Katlama C; Calvez V; Marcelin AG
Antivir Ther; 2009; 14(1):123-9. PubMed ID: 19320246
[TBL] [Abstract][Full Text] [Related]
17. Molecular evolution of HIV-1 integrase during the 20 years prior to the first approval of integrase inhibitors.
Meixenberger K; Yousef KP; Smith MR; Somogyi S; Fiedler S; Bartmeyer B; Hamouda O; Bannert N; von Kleist M; Kücherer C
Virol J; 2017 Nov; 14(1):223. PubMed ID: 29137637
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of integrase strand transfer inhibitor (INSTIs) resistance mutations in Henan Province, China (2018-2020).
Yang Z; Yang X; Deng X; Wei S; Liu J; Ma J; Zhao Q; Huo Y
Infection; 2021 Dec; 49(6):1195-1202. PubMed ID: 34279816
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 Integrase Resistance among Highly Antiretroviral Experienced Patients from Morocco.
Alaoui N; El Alaoui MA; El Annaz H; Farissi FZ; Alaoui AS; El Fahime E; Mrani S
Intervirology; 2019; 62(2):65-71. PubMed ID: 31307042
[TBL] [Abstract][Full Text] [Related]
20. Lack of impact of pre-existing T97A HIV-1 integrase mutation on integrase strand transfer inhibitor resistance and treatment outcome.
Abram ME; Ram RR; Margot NA; Barnes TL; White KL; Callebaut C; Miller MD
PLoS One; 2017; 12(2):e0172206. PubMed ID: 28212411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]